Notably, BCL2 expression may correlate with prognosis, since negative cases were enriched for higher grade morphology (including five cases transformed to DLBCL) when compared with BCL2-positive cases [22]. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.